These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16622409)

  • 21. Crystal structure of Clostridium difficile toxin A.
    Chumbler NM; Rutherford SA; Zhang Z; Farrow MA; Lisher JP; Farquhar E; Giedroc DP; Spiller BW; Melnyk RA; Lacy DB
    Nat Microbiol; 2016 Jan; 1():15002. PubMed ID: 27571750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular uptake of Clostridium difficile TcdA and truncated TcdA lacking the receptor binding domain.
    Gerhard R; Frenzel E; Goy S; Olling A
    J Med Microbiol; 2013 Sep; 62(Pt 9):1414-1422. PubMed ID: 23558138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for dual receptor-binding sites in Clostridium difficile toxin A.
    Lambert GS; Baldwin MR
    FEBS Lett; 2016 Dec; 590(24):4550-4563. PubMed ID: 27861794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptation of Clostridium difficile toxin A for use as a protein translocation system.
    Kern SM; Feig AL
    Biochem Biophys Res Commun; 2011 Feb; 405(4):570-4. PubMed ID: 21266163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific binding of nucleotides and NAD+ to Clostridium difficile toxin A.
    Lobban MD; Borriello SP
    FEBS Lett; 1992 Feb; 298(2-3):185-7. PubMed ID: 1544441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multivalent binding of toxin A from Clostridium difficile to carbohydrate receptors.
    Wolfhagen MJ; Torensma R; Fluit AC; Aarsman CJ; Jansze M; Verhoef J
    Toxicon; 1994 Jan; 32(1):129-32. PubMed ID: 9237345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of varying concentrations of clostridium difficile toxin A on epithelial barrier function and expression of cytokines.
    Johal SS; Solomon K; Dodson S; Borriello SP; Mahida YR
    J Infect Dis; 2004 Jun; 189(11):2110-9. PubMed ID: 15143480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformational changes and reaction of clostridial glycosylating toxins.
    Ziegler MO; Jank T; Aktories K; Schulz GE
    J Mol Biol; 2008 Apr; 377(5):1346-56. PubMed ID: 18325534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure and mode of action of clostridial glucosylating toxins: the ABCD model.
    Jank T; Aktories K
    Trends Microbiol; 2008 May; 16(5):222-9. PubMed ID: 18394902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxin production by and adhesive properties of Clostridium difficile isolated from humans and horses with antibiotic-associated diarrhea.
    Taha S; Johansson O; Rivera Jonsson S; Heimer D; Krovacek K
    Comp Immunol Microbiol Infect Dis; 2007 May; 30(3):163-74. PubMed ID: 17239950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection.
    Persson S; Torpdahl M; Olsen KE
    Clin Microbiol Infect; 2008 Nov; 14(11):1057-64. PubMed ID: 19040478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recognition of human milk oligosaccharides by bacterial exotoxins.
    El-Hawiet A; Kitova EN; Klassen JS
    Glycobiology; 2015 Aug; 25(8):845-54. PubMed ID: 25941008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutralizing hospital-acquired infections.
    Harrington M
    Lab Anim (NY); 2011 Sep; 40(10):288. PubMed ID: 22358194
    [No Abstract]   [Full Text] [Related]  

  • 34. Sulfated glycosaminoglycans and low-density lipoprotein receptor contribute to Clostridium difficile toxin A entry into cells.
    Tao L; Tian S; Zhang J; Liu Z; Robinson-McCarthy L; Miyashita SI; Breault DT; Gerhard R; Oottamasathien S; Whelan SPJ; Dong M
    Nat Microbiol; 2019 Oct; 4(10):1760-1769. PubMed ID: 31160825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The attachment, internalization, and time-dependent, intracellular distribution of Clostridium difficile toxin A in porcine intestinal explants.
    Keel MK; Songer JG
    Vet Pathol; 2011 Mar; 48(2):369-80. PubMed ID: 20861504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure of the cell-binding component of the
    Xu X; Godoy-Ruiz R; Adipietro KA; Peralta C; Ben-Hail D; Varney KM; Cook ME; Roth BM; Wilder PT; Cleveland T; Grishaev A; Neu HM; Michel SLJ; Yu W; Beckett D; Rustandi RR; Lancaster C; Loughney JW; Kristopeit A; Christanti S; Olson JW; MacKerell AD; Georges AD; Pozharski E; Weber DJ
    Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1049-1058. PubMed ID: 31896582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging toxin A-B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea.
    Shin BM; Kuak EY; Yoo SJ; Shin WC; Yoo HM
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):333-7. PubMed ID: 18082994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unexpected structure of a C. difficile toxin A ligand necessitates an annotation correction in a popular screening library.
    Zhang P; Razi N; Eugenio L; Fentabil M; Kitova EN; Klassen JS; Bundle DR; Ng KK; Ling CC
    Chem Commun (Camb); 2011 Dec; 47(45):12397-9. PubMed ID: 22016886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholesterol, it's not just for heart disease anymore.
    Kerzmann A; Feig AL
    ACS Chem Biol; 2006 Apr; 1(3):141-4. PubMed ID: 17163660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clostridium difficile--Second International Symposium (ICDS).
    Tillotson G
    IDrugs; 2007 Aug; 10(8):538-42. PubMed ID: 17665327
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.